General AML

Gert Ossenkoppele | EHA 2018 | Non-intensive treatment strategies in AML: New hope for unfit AML patients


At the 2018 European Hematology Assiociation Meeting, Gert Ossenkoppele (chair our Global and European steering committee) from VU Medical Center, Amsterdam, NL, talks about non-intensive treatment strategies for elderly acute myeloid leukemia (AML) including the use of venetoclax in combination with hypomethylating agents.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF